- call +1-201-465-4211
- email sales@mrinsights.biz
Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells.
Scope of the Report:
This report studies the Cancer Genome Sequencing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Genome Sequencing market by product type and applications/end industries.
It is a laboratory technique that characterizes DNA or RNA sequences of primary tumor tissue, the tumor micro environment (such as stromal / fibroblast cells), adjacent or distal normal tissue, or metastatic tumor sites. This technique generates information related to identification of nucleotide bases (DNA or RNA), mutation status, copy number and sequence variants, as well as structural variations including fusion genes and chromosomal translocations.
The global Cancer Genome Sequencing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Genome Sequencing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Agilent Technologies
GE Healthcare Life Sciences
Johnson & Johnson
LI-COR Biosciences
Abbott Laboratories
Beckman Coulter
Bayer Corporation
Hamilton Thorne Biosciences
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Second generation
Third generation
Market Segment by Applications, can be divided into
Treatment
Research
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Cancer Genome Sequencing Market Overview
1.1 Product Overview and Scope of Cancer Genome Sequencing
1.2 Classification of Cancer Genome Sequencing by Types
1.2.1 Global Cancer Genome Sequencing Revenue Comparison by Types (2017-2023)
1.2.2 Global Cancer Genome Sequencing Revenue Market Share by Types in 2017
1.2.3 Second generation
1.2.4 Third generation
1.3 Global Cancer Genome Sequencing Market by Application
1.3.1 Global Cancer Genome Sequencing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Treatment
1.3.3 Research
1.4 Global Cancer Genome Sequencing Market by Regions
1.4.1 Global Cancer Genome Sequencing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cancer Genome Sequencing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Genome Sequencing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Genome Sequencing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Genome Sequencing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Genome Sequencing Status and Prospect (2013-2023)
1.5 Global Market Size of Cancer Genome Sequencing (2013-2023)
2 Manufacturers Profiles
2.1 Agilent Technologies
2.1.1 Business Overview
2.1.2 Cancer Genome Sequencing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Agilent Technologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.2 GE Healthcare Life Sciences
2.2.1 Business Overview
2.2.2 Cancer Genome Sequencing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Cancer Genome Sequencing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.4 LI-COR Biosciences
2.4.1 Business Overview
2.4.2 Cancer Genome Sequencing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 LI-COR Biosciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Abbott Laboratories
2.5.1 Business Overview
2.5.2 Cancer Genome Sequencing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Laboratories Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Beckman Coulter
2.6.1 Business Overview
2.6.2 Cancer Genome Sequencing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Beckman Coulter Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bayer Corporation
2.7.1 Business Overview
2.7.2 Cancer Genome Sequencing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bayer Corporation Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Hamilton Thorne Biosciences
2.8.1 Business Overview
2.8.2 Cancer Genome Sequencing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Integrated DNA Technologies
2.9.1 Business Overview
2.9.2 Cancer Genome Sequencing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Integrated DNA Technologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Microchip Biotechnologies
2.10.1 Business Overview
2.10.2 Cancer Genome Sequencing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Microchip Biotechnologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.11 Myriad Genetics
2.11.1 Business Overview
2.11.2 Cancer Genome Sequencing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Myriad Genetics Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.12 Commonwealth Biotechnologies
2.12.1 Business Overview
2.12.2 Cancer Genome Sequencing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.13 ZS Genetics
2.13.1 Business Overview
2.13.2 Cancer Genome Sequencing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 ZS Genetics Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.14 Pacific Biosciences
2.14.1 Business Overview
2.14.2 Cancer Genome Sequencing Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Pacific Biosciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Genome Sequencing Market Competition, by Players
3.1 Global Cancer Genome Sequencing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Genome Sequencing Players Market Share
3.2.2 Top 10 Cancer Genome Sequencing Players Market Share
3.3 Market Competition Trend
4 Global Cancer Genome Sequencing Market Size by Regions
4.1 Global Cancer Genome Sequencing Revenue and Market Share by Regions
4.2 North America Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
4.3 Europe Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
4.5 South America Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
5 North America Cancer Genome Sequencing Revenue by Countries
5.1 North America Cancer Genome Sequencing Revenue by Countries (2013-2018)
5.2 USA Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
5.3 Canada Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
5.4 Mexico Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
6 Europe Cancer Genome Sequencing Revenue by Countries
6.1 Europe Cancer Genome Sequencing Revenue by Countries (2013-2018)
6.2 Germany Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
6.3 UK Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
6.4 France Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
6.5 Russia Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
6.6 Italy Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Cancer Genome Sequencing Revenue by Countries
7.1 Asia-Pacific Cancer Genome Sequencing Revenue by Countries (2013-2018)
7.2 China Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
7.3 Japan Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
7.4 Korea Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
7.5 India Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
8 South America Cancer Genome Sequencing Revenue by Countries
8.1 South America Cancer Genome Sequencing Revenue by Countries (2013-2018)
8.2 Brazil Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
8.3 Argentina Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
8.4 Colombia Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Cancer Genome Sequencing by Countries
9.1 Middle East and Africa Cancer Genome Sequencing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
9.3 UAE Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
9.4 Egypt Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
9.6 South Africa Cancer Genome Sequencing Revenue and Growth Rate (2013-2018)
10 Global Cancer Genome Sequencing Market Segment by Type
10.1 Global Cancer Genome Sequencing Revenue and Market Share by Type (2013-2018)
10.2 Global Cancer Genome Sequencing Market Forecast by Type (2018-2023)
10.3 Second generation Revenue Growth Rate (2013-2023)
10.4 Third generation Revenue Growth Rate (2013-2023)
11 Global Cancer Genome Sequencing Market Segment by Application
11.1 Global Cancer Genome Sequencing Revenue Market Share by Application (2013-2018)
11.2 Cancer Genome Sequencing Market Forecast by Application (2018-2023)
11.3 Treatment Revenue Growth (2013-2018)
11.4 Research Revenue Growth (2013-2018)
12 Global Cancer Genome Sequencing Market Size Forecast (2018-2023)
12.1 Global Cancer Genome Sequencing Market Size Forecast (2018-2023)
12.2 Global Cancer Genome Sequencing Market Forecast by Regions (2018-2023)
12.3 North America Cancer Genome Sequencing Revenue Market Forecast (2018-2023)
12.4 Europe Cancer Genome Sequencing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cancer Genome Sequencing Revenue Market Forecast (2018-2023)
12.6 South America Cancer Genome Sequencing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cancer Genome Sequencing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Cancer Genome Sequencing Picture
Table Product Specifications of Cancer Genome Sequencing
Table Global Cancer Genome Sequencing and Revenue (Million USD) Market Spli
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
